Header Logo

Andrew Ambrosy, MD

TitleResearch Scientist I
InstitutionKaiser Permanente Northern California
DepartmentDivision of Research
Address2000 Broadway
Oakland CA 94612
ORCID ORCID IconLogin to create your ORCID iD Additional info
vCardDownload vCard
    Other Positions
    TitleAssistant Medical Director, Clinical Trials Program
    InstitutionKaiser Permanente Northern California
    DepartmentDivision of Research


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Ambrosy AP, Chang AJ, Davison B, Voors A, Cohen-Solal A, Damasceno A, Kimmoun A, Lam CSP, Edwards C, Tomasoni D, Gayat E, Filippatos G, Saidu H, Biegus J, Celutkiene J, Ter Maaten JM, Cerlinskaite-Bajore K, Sliwa K, Takagi K, Metra M, Novosadova M, Barros M, Adamo M, Pagnesi M, Arrigo M, Chioncel O, Diaz R, Pang PS, Ponikowski P, Cotter G, Mebazaa A. Titration of Medications After Acute Heart?Failure Is Safe, Tolerated, and Effective Regardless of Risk. JACC Heart Fail. 2024 May 12. PMID: 38739123.
      Citations: 1     Fields:    Translation:Humans
    2. Ambrosy AP, Go AS, Leong TK, Garcia EA, Chang AJ, Slade JJ, McNulty EJ, Mishell JM, Rassi AN, Ku IA, Lange DC, Philips F, Galper BZ, Berry N, Solomon MD. Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort. Int J Cardiol. 2023 Apr 27. PMID: 37119944.
      Citations: 2     Fields:    Translation:Humans
    3. Feng KY, Ambrosy AP, Zhou Z, Li D, Kong J, Zaroff JG, Mishell JM, Ku IA, Scotti A, Coisne A, Redfors B, Mack MJ, Abraham WT, Lindenfeld J, Stone GW, COAPT trial investigators. Association Between Serum Albumin and Outcomes in Heart Failure and Secondary Mitral Regurgitation: The COAPT Trial. Eur J Heart Fail. 2023 Feb 23. PMID: 36823954.
      Citations: 7     Fields:    Translation:Humans
    4. Salah HM, Savarese G, Rosano GMC, Ambrosy AP, Mentz RJ, Fudim M. Intravenous iron infusion in patients with heart failure: a systematic review and study-level meta-analysis. ESC Heart Fail. 2023 Feb 02. PMID: 36734033.
      Citations: 9     Fields:    Translation:Humans
    5. Tisdale RL, Fan J, Calma J, Cyr K, Podchiyska T, Stafford RS, Maron DJ, Hernandez-Boussard T, Ambrosy A, Heidenreich PA, Sandhu AT. Predictors of Incident Heart?Failure Diagnosis Setting: Insights From the Veterans Affairs Healthcare System. JACC Heart Fail. 2023 03; 11(3):347-358. PMID: 36881392; PMCID: PMC10069381.
      Citations: 1     Fields:    Translation:Humans
    6. Savitz ST, Leong T, Sung SH, Kitzman DW, McNulty E, Mishell J, Rassi A, Ambrosy AP, Go AS. Predicting short-term outcomes after transcatheter aortic valve replacement for aortic stenosis. Am Heart J. 2023 02; 256:60-72. PMID: 36372246; PMCID: PMC9840674.
      Citations:    Fields:    Translation:Humans
    7. Lam JO, Leyden WA, Leong TK, Horberg MA, Reynolds K, Ambrosy AP, Avula HR, Hechter RC, Towner WJ, Vupputuri S, Go AS, Silverberg MJ. Variation in Heart Failure Risk by HIV Severity and Sex in People With HIV Infection. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):175-181. PMID: 36094484; PMCID: PMC9471068.
      Citations: 2     Fields:    Translation:Humans
    8. Palazzuoli A, Metra M, Collins SP, Adamo M, Ambrosy AP, Antohi LE, Ben Gal T, Farmakis D, Gustafsson F, Hill L, Lopatin Y, Tramonte F, Lyon A, Masip J, Miro O, Moura B, Mullens W, Radu RI, Abdelhamid M, Anker S, Chioncel O. Heart failure during the COVID-19 pandemic: clinical, diagnostic, management, and organizational dilemmas. ESC Heart Fail. 2022 12; 9(6):3713-3736. PMID: 36111511; PMCID: PMC9773739.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    9. Peters AE, Chiswell K, Hofmann P, Ambrosy A, Fudim M. Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020. Am J Cardiol. 2022 11 15; 183:129-136. PMID: 36089419; PMCID: PMC9588603.
      Citations: 3     Fields:    Translation:Humans
    10. Merlo A, Mezue K, Ambrosy AP. Fluid Restriction Recommendations in Heart Failure: Dry as a Bone or Quench Your Thirst? J Card Fail. 2022 10; 28(10):1531-1533. PMID: 35977689.
      Citations:    Fields:    Translation:Humans
    11. Go AS, Tan TC, Horiuchi KM, Laws D, Ambrosy AP, Lee KK, Maring BL, Joy J, Couch C, Hepfer P, Lo JC, Parikh RV, KP NOURISH Study Investigators. Effect of Medically Tailored Meals on Clinical Outcomes in Recently Hospitalized High-Risk Adults. Med Care. 2022 10 01; 60(10):750-758. PMID: 35972131; PMCID: PMC9451942.
      Citations: 7     Fields:    Translation:Humans
    12. Ambrosy AP, Parikh RV, Sung SH, Tan TC, Narayanan A, Masson R, Lam PQ, Kheder K, Iwahashi A, Hardwick AB, Fitzpatrick JK, Avula HR, Selby VN, Ku IA, Shen X, Sanghera N, Cristino J, Go AS. Analysis of Worsening Heart Failure Events in an Integrated Health Care System. J Am Coll Cardiol. 2022 Jul 12; 80(2):111-122. PMID: 35798445.
      Citations: 9     Fields:    Translation:Humans
    13. Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ. Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician. Curr Atheroscler Rep. 2022 Jul; 24(7):563-570. PMID: 35507278; PMCID: PMC9065238.
      Citations: 31     Fields:    Translation:HumansCells
    14. Fitzpatrick JK, Ambrosy AP, Parikh RV, Tan TC, Bansal N, Go AS, CRIC Study Investigators,. Prognostic value of echocardiography for heart failure and death in adults with chronic kidney disease. Am Heart J. 2022 Mar 10; 248:84-96. PMID: 35278374.
      Citations: 4     Fields:    Translation:Humans
    15. Sawicki KT, Ambrosy AP. Heart Failure With Iron Deficiency Across the Left Ventricular Ejection Fraction Continuum: Need to Redefine? J Card Fail. 2022 Feb 11. PMID: 35158026.
      Citations: 1     Fields:    Translation:Humans
    16. Sharma A, Elharram M, Afilalo J, Flannery A, Afilalo M, Tselios C, Ni J, Ezekowitz JA, Cheng MP, Ambrosy AP, Zannad F, Brophy JM, Giannetti N, Bessissow A, Kronfli N, Marelli A, Aziz H, Alqahtani M, Aflaki M, Craig M, Lopes RD, Ferreira JP. A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19. Am Heart J. 2022 May; 247:76-89. PMID: 35143744; PMCID: PMC8820148.
      Citations: 7     Fields:    Translation:Humans
    17. Ambrosy AP, Malik UI, Leong TK, Allen AR, Sung SH, Go AS, Healthy Eating as a Means for Active Living in Heart Failure (HEAL-HF) Study. Food security, diet quality, nutritional knowledge, and attitudes towards research in adults with heart failure during the COVID-19 pandemic. Clin Cardiol. 2022 Feb; 45(2):180-188. PMID: 35106780; PMCID: PMC8860486.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    18. Fitzpatrick JK, Yang J, Ambrosy AP, Cabrera C, Stefansson BV, Greasley PJ, Patel J, Tan TC, Go AS. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study. BMJ Open. 2022 01 31; 12(1):e048755. PMID: 35105612; PMCID: PMC8808372.
      Citations: 4     Fields:    Translation:Humans
    19. Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, Vaduganathan M, Greene SJ, Pandey A, Fudim M. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022 04; 9(2):947-952. PMID: 35098700; PMCID: PMC8934991.
      Citations: 8     Fields:    Translation:Humans
    20. Wagner JR, Fitzpatrick JK, Yang J, Sung SH, Allen AR, Philip S, Granowitz C, Abrahamson D, Ambrosy AP, Go AS. Global assessment improves risk stratification for major adverse cardiac events across a wide range of triglyceride levels: Insights from the KP REACH study. Am J Prev Cardiol. 2022 Mar; 9:100319. PMID: 35199077; PMCID: PMC8844399.
      Citations: 1     
    21. Avula HR, Ambrosy AP, Silverberg MJ, Reynolds K, Towner WJ, Hechter RC, Horberg M, Vupputuri S, Leong TK, Leyden WA, Harrison TN, Lee KK, Sung SH, Go AS. Human immunodeficiency virus infection and risks of morbidity and death in adults with incident heart failure. Eur Heart J Open. 2021 Nov; 1(3):oeab040. PMID: 35919879; PMCID: PMC9242035.
      Citations: 3     
    22. Ambrosy AP, Parikh RV, Sung SH, Narayanan A, Masson R, Lam PQ, Kheder K, Iwahashi A, Hardwick AB, Fitzpatrick JK, Avula HR, Selby VN, Shen X, Sanghera N, Cristino J, Go AS. A Natural Language Processing-Based Approach for Identifying Hospitalizations for Worsening Heart Failure Within an Integrated Health Care Delivery System. JAMA Netw Open. 2021 11 01; 4(11):e2135152. PMID: 34807259; PMCID: PMC8609413.
      Citations: 9     Fields:    Translation:Humans
    23. Radu RI, Ben Gal T, Abdelhamid M, Antohi EL, Adamo M, Ambrosy AP, Geavlete O, Lopatin Y, Lyon A, Miro O, Metra M, Parissis J, Collins SP, Anker SD, Chioncel O. Antithrombotic and anticoagulation therapies in cardiogenic shock: a critical review of the published literature. ESC Heart Fail. 2021 Dec; 8(6):4717-4736. PMID: 34664409; PMCID: PMC8712803.
      Citations: 3     Fields:    Translation:Humans
    24. Ambrosy AP, Yang J, Sung SH, Allen AR, Fitzpatrick JK, Rana JS, Wagner J, Philip S, Abrahamson D, Granowitz C, Go AS. Triglyceride Levels and Residual Risk of Atherosclerotic Cardiovascular Disease Events and Death in Adults Receiving Statin Therapy for Primary or Secondary Prevention: Insights From the KP REACH Study. J Am Heart Assoc. 2021 10 19; 10(20):e020377. PMID: 34622663; PMCID: PMC8751901.
      Citations: 10     Fields:    Translation:Humans
    25. Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, Vaduganathan M, Greene SJ, Pandey A, Fudim M. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. Am Heart J. 2022 Jan; 243:103-109. PMID: 34582776.
      Citations: 11     Fields:    Translation:Humans
    26. Go AS, Tan TC, Parikh RV, Ambrosy AP, Pravoverov LV, Zheng S, Leong TK. Timing of AKI after urgent percutaneous coronary intervention and clinical outcomes: a high-dimensional propensity score analysis. BMC Nephrol. 2021 Sep 06; 22(1):300. PMID: 34482839; PMCID: PMC8418923.
      Citations: 2     Fields:    Translation:Humans
    27. Vafaei P, Naderi S, Ambrosy AP, Slade JJ. Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease. Curr Atheroscler Rep. 2021 Sep 01; 23(11):70. PMID: 34468881.
      Citations: 1     Fields:    Translation:Humans
    28. Morrill J, Qirko K, Kelly J, Ambrosy A, Toro B, Smith T, Wysham N, Fudim M, Swaminathan S. A Machine Learning Methodology for Identification and Triage of Heart Failure Exacerbations. J Cardiovasc Transl Res. 2021 Aug 28. PMID: 34453676; PMCID: PMC8397870.
      Citations: 5     Fields:    Translation:Humans
    29. Kosmopoulos A, Bhatt DL, Meglis G, Verma R, Pan Y, Quan A, Teoh H, Verma M, Jiao L, Wang R, Juliano RA, Kajil M, Kosiborod MN, Bari B, Berih AA, Aguilar M, Escano A, Leung A, Coelho I, Hibino M, Díaz R, Mason RP, Steg PG, Simon T, Go AS, Ambrosy AP, Choi R, Kushner AM, Leiter LA, Al-Omran M, Verma S, Mazer CD. A randomized trial of icosapent ethyl in ambulatory patients with COVID-19. iScience. 2021 Sep 24; 24(9):103040. PMID: 34462732; PMCID: PMC8388138.
      Citations: 12     
    30. Varshney AS, Minhas AMK, Bhatt AS, Ambrosy AP, Fudim M, Vaduganathan M. Contemporary Burden of Primary Versus Secondary Heart Failure Hospitalizations in the United States. Am J Cardiol. 2021 Oct 01; 156:140-142. PMID: 34315568.
      Citations: 1     Fields:    Translation:Humans
    31. Ambrosy AP, von Haehling S, Kalra PR, Court E, Bhandari S, McDonagh T, Cleland JGF. Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure. Am J Cardiol. 2021 08 01; 152:138-145. PMID: 34162484.
      Citations: 12     Fields:    Translation:Humans
    32. Sharma A, Greene S, Vaduganathan M, Fudim M, Ambrosy AP, Sun JL, McNulty SE, Hernandez AF, Borlaug BA, Velazquez EJ, Mentz RJ, DeVore AD, Alhanti B, Margulies K, Felker GM. Growth differentiation factor-15, treatment with liraglutide, and clinical outcomes among patients with heart failure. ESC Heart Fail. 2021 Aug; 8(4):2608-2616. PMID: 34061470; PMCID: PMC8318489.
      Citations: 5     Fields:    Translation:Humans
    33. Tai A, Ambrosy AP, Fudim M. Making the case for sacubitril/valsartan in patients with heart failure with a preserved ejection fraction. Eur Heart J Cardiovasc Pharmacother. 2021 May 23; 7(3):e5-e6. PMID: 33537712; PMCID: PMC8141300.
      Citations:    Fields:    Translation:Humans
    34. Mentz RJ, Ambrosy AP, Ezekowitz JA, Lewis GD, Butler J, Wong YW, De Pasquale CG, Troughton RW, O'Meara E, Rockhold FW, Garg J, Samsky MD, Leloudis D, Dugan M, Mundy LM, Hernandez AF, HEART-FID Trial Investigators. Randomized Placebo-Controlled Trial of Ferric Carboxymaltose in Heart Failure With Iron Deficiency: Rationale and Design. Circ Heart Fail. 2021 May; 14(5):e008100. PMID: 34003690; PMCID: PMC8136455.
      Citations: 16     Fields:    Translation:Humans
    35. Chen S, Merchant M, Mahrer KN, Ambrosy AP, Lundstrom RJ, Naderi S. Pregnancy-Associated Spontaneous Coronary Artery Dissection: Clinical Characteristics, Outcomes, and Risk During Subsequent Pregnancy. J Invasive Cardiol. 2021 06; 33(6):E457-E466. PMID: 34001675.
      Citations: 9     Fields:    Translation:Humans
    36. Chioncel O, Ambrosy AP, Maggioni AP. Temporal trends in the outcomes of acute heart failure: between consolatory evidences and real progress. Eur J Heart Fail. 2021 03; 23(3):432-435. PMID: 33599362.
      Citations: 1     Fields:    Translation:Humans
    37. Aflaki M, Flannery A, Ferreira JP, Cheng MP, Kronfli N, Marelli A, Zannad F, Brophy J, Afillalo J, Huynh T, Giannetti N, Bessissow A, Ezekowitz JA, Lopes RD, Ambrosy AP, Craig M, Sharma A. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Trials. 2021 Feb 05; 22(1):115. PMID: 33546734; PMCID: PMC7862851.
      Citations: 2     Fields:    Translation:HumansCellsCTClinical Trials
    38. Rao VN, Pandey A, Zhong L, Ambrosy AP, Fudim M. Loop Diuretic Use and Outcomes in Chronic Stable Heart Failure With Preserved Ejection Fraction-Reply. Mayo Clin Proc. 2021 02; 96(2):503-506. PMID: 33549271; PMCID: PMC8020763.
      Citations: 1     Fields:    Translation:Humans
    39. Campbell CI, Saxon AJ, Boudreau DM, Wartko PD, Bobb JF, Lee AK, Matthews AG, McCormack J, Liu DS, Addis M, Altschuler A, Samet JH, LaBelle CT, Arnsten J, Caldeiro RM, Borst DT, Stotts AL, Braciszewski JM, Szapocznik J, Bart G, Schwartz RP, McNeely J, Liebschutz JM, Tsui JI, Merrill JO, Glass JE, Lapham GT, Murphy SM, Weinstein ZM, Yarborough BJH, Bradley KA. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment. Addict Sci Clin Pract. 2021 01 31; 16(1):9. PMID: 33517894; PMCID: PMC7849121.
      Citations: 25     Fields:    Translation:HumansCTClinical Trials
    40. Ambrosy AP, Malik UI, Thomas RC, Parikh RV, Tan TC, Goh CH, Selby VN, Solomon MD, Avula HR, Fitzpatrick JK, Skarbinski J, Philip S, Granowitz C, Bhatt DL, Go AS. Rationale and design of the pragmatic randomized trial of icosapent ethyl for high cardiovascular risk adults (MITIGATE). Am Heart J. 2021 05; 235:54-64. PMID: 33516752; PMCID: PMC7843090.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    41. Fudim M, Ashur N, Jones AD, Ambrosy AP, Bart BA, Butler J, Chen HH, Greene SJ, Reddy Y, Redfield MM, Sharma A, Hernandez AF, Felker GM, Borlaug BA, Mentz RJ. Implications of peripheral oedema in heart failure with preserved ejection fraction: a heart failure network analysis. ESC Heart Fail. 2021 02; 8(1):662-669. PMID: 33300277; PMCID: PMC7835593.
      Citations: 3     Fields:    Translation:Humans
    42. Chioncel O, Ambrosy AP. Improving adherence to guideline-directed medical therapies and outcomes in the developing world: A call to end global inequities in heart failure. Int J Cardiol. 2021 04 15; 329:74-76. PMID: 33278414.
      Citations:    Fields:    Translation:Humans
    43. Wagner JR, Ambrosy AP. Hospitalizations for heart failure and mortality risk during the evolving coronavirus disease 2019 pandemic - the wave may break but a dangerous undertow persists. Eur J Heart Fail. 2020 12; 22(12):2225-2227. PMID: 33125819.
      Citations: 2     Fields:    Translation:HumansCellsPHPublic Health
    44. Kleiner-Shochat M, Kapustin D, Fudim M, Ambrosy AP, Glantz J, Kazatsker M, Kleiner I, Weinstein JM, Panjrath G, Roguin A, Meisel SR. The Degree of the Predischarge Pulmonary Congestion in Patients Hospitalized for Worsening Heart Failure Predicts Readmission and Mortality. Cardiology. 2021; 146(1):49-59. PMID: 33113535.
      Citations: 2     Fields:    Translation:Humans
    45. Malik UI, Ambrosy AP, Ku IA, Mishell JM, Kar S, Lim DS, Whisenant BK, Cohen DJ, Arnold SV, Kotinkaduwa LN, Lindenfeld J, Abraham WT, Mack MJ, Stone GW. Baseline Functional Capacity and Transcatheter Mitral Valve Repair in Heart Failure With Secondary Mitral Regurgitation. JACC Cardiovasc Interv. 2020 10 26; 13(20):2331-2341. PMID: 33092707.
      Citations: 3     Fields:    Translation:Humans
    46. Berardi C, Braunwald E, Morrow DA, Mulder HS, Duffy CI, O'Brien TX, Ambrosy AP, Chakraborty H, Velazquez EJ, DeVore AD, PIONEER-HF Investigators. Angiotensin-Neprilysin Inhibition in Black Americans: Data From the PIONEER-HF Trial. JACC Heart Fail. 2020 10; 8(10):859-866. PMID: 32919915.
      Citations: 10     Fields:    Translation:Humans
    47. Ambrosy AP, Braunwald E, Morrow DA, DeVore AD, McCague K, Meng X, Duffy CI, Rocha R, Velazquez EJ, PIONEER-HF Investigators. Angiotensin Receptor-Neprilysin Inhibition Based on History of Heart Failure and Use of Renin-Angiotensin System Antagonists. J Am Coll Cardiol. 2020 09 01; 76(9):1034-1048. PMID: 32854838.
      Citations: 20     Fields:    Translation:Humans
    48. Ambrosy AP, Fitzpatrick JK, Fudim M. Hospitalizations for heart failure during the COVID-19 pandemic: making sense of the known knowns, known unknowns, and unknown unknowns. Eur J Heart Fail. 2020 10; 22(10):1752-1754. PMID: 32946154.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    49. Ambrosy AP, Chioncel O. Improving physical activity and exercise capacity in heart failure. Taking the first step is always the hardest. Eur J Heart Fail. 2020 09; 22(9):1734-1736. PMID: 32533732.
      Citations:    Fields:    Translation:Humans
    50. Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, DeVore AD, Gorodeski EZ, Desvigne-Nickens P, Hernandez AF, Braunwald E, LIFE Investigators. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. JACC Heart Fail. 2020 10; 8(10):789-799. PMID: 32641226; PMCID: PMC7286640.
      Citations: 20     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    51. Fudim M, Ali-Ahmed F, Parzynski CS, Ambrosy AP, Friedman DJ, Pokorney SD, Curtis JP, Fonarow GC, Masoudi FA, Hernandez AF, Al-Khatib SM. Periprocedural Risk and Survival Associated With Implantable Cardioverter-Defibrillator Placement in Older Patients With Advanced Heart Failure. JAMA Cardiol. 2020 06 01; 5(6):643-651. PMID: 32211811; PMCID: PMC7097837.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    52. Solomon MD, McNulty EJ, Rana JS, Leong TK, Lee C, Sung SH, Ambrosy AP, Sidney S, Go AS. The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction. N Engl J Med. 2020 08 13; 383(7):691-693. PMID: 32427432.
      Citations: 358     Fields:    Translation:HumansPHPublic Health
    53. Redouane B, Greene SJ, Fudim M, Vaduganathan M, Ambrosy AP, Sun JL, DeVore AD, McNulty SE, Mentz RJ, Hernandez AF, Felker GM, Cooper LB, Borlaug BA, Velazquez EJ, Margulies KB, Sharma A. Effects of Liraglutide on Worsening Renal Function Among Patients With Heart Failure With Reduced Ejection Fraction: Insights From the FIGHT Trial. Circ Heart Fail. 2020 05; 13(5):e006758. PMID: 32362166; PMCID: PMC7906045.
      Citations: 6     Fields:    Translation:Humans
    54. Bhatt AS, Ambrosy AP, Dunning A, DeVore AD, Butler J, Reed S, Voors A, Starling R, Armstrong PW, Ezekowitz JA, Metra M, Hernandez AF, O'Connor CM, Mentz RJ. The burden of non-cardiac comorbidities and association with clinical outcomes in an acute heart failure trial - insights from ASCEND-HF. Eur J Heart Fail. 2020 06; 22(6):1022-1031. PMID: 32212297; PMCID: PMC7394726.
      Citations: 10     Fields:    Translation:Humans
    55. Ambrosy AP, Fitzpatrick JK, Tabada GH, Gurwitz JH, Artz A, Schrier SL, Rao SV, Reynolds K, Smith DH, Peterson PN, Fortmann SP, Sung SH, Cohen HJ, Go AS, RBC HEART Investigators/PACTTE Consortium. A reduced transferrin saturation is independently associated with excess morbidity and mortality in older adults with heart failure and incident anemia. Int J Cardiol. 2020 06 15; 309:95-99. PMID: 32201101.
      Citations: 7     Fields:    Translation:Humans
    56. Fudim M, Carlisle MA, Devaraj S, Ajam T, Ambrosy AP, Pokorney SD, Al-Khatib SM, Kamalesh M. One-year mortality after implantable cardioverter-defibrillator placement within the Veterans Affairs Health System. Eur J Heart Fail. 2020 05; 22(5):859-867. PMID: 32108984.
      Citations: 9     Fields:    Translation:HumansPHPublic Health
    57. Chen S, Ambrosy AP, Mahrer KN, Lundstrom RJ, Naderi S. Spontaneous Coronary Artery Dissection and Incident Ventricular Arrhythmias: Frequency, Clinical Characteristics, and Outcomes. JACC Cardiovasc Interv. 2020 02 24; 13(4):539-541. PMID: 32081249.
      Citations: 3     Fields:    Translation:Humans
    58. Rana JS, Liu JY, Moffet HH, Karter AJ, Nasir K, Solomon MD, Jaffe MG, Ambrosy AP, Go AS, Sidney S. Risk of atherosclerotic cardiovascular disease by cardiovascular health metric categories in approximately 1 million patients. Eur J Prev Cardiol. 2020 Feb 10; 2047487320905025. PMID: 32039636.
      Citations: 4     Fields:    
    59. Rana JS, Liu JY, Moffet HH, Karter AJ, Nasir K, Solomon MD, Jaffe MG, Ambrosy AP, Go AS, Sidney S. Risk of atherosclerotic cardiovascular disease by cardiovascular health metric categories in approximately 1 million patients. Eur J Prev Cardiol. 2020 Feb 07. PMID: 33611408.
      Citations: 8     Fields:    
    60. DeVore AD, Braunwald E, Morrow DA, Duffy CI, Ambrosy AP, Chakraborty H, McCague K, Rocha R, Velazquez EJ, PIONEER-HF Investigators. Initiation of Angiotensin-Neprilysin Inhibition After Acute Decompensated Heart Failure: Secondary Analysis of the Open-label Extension of the PIONEER-HF Trial. JAMA Cardiol. 2020 02 01; 5(2):202-207. PMID: 31825471; PMCID: PMC6990764.
      Citations: 31     Fields:    Translation:Humans
    61. Masson R, Ambrosy AP, Kheder K, Fudim M, Clare RM, Coles A, Hernandez AF, Starling RC, Ezekowitz JA, O'Connor CM, Mentz RJ. A Novel In-hospital Congestion Score to Risk Stratify Patients Admitted for Worsening Heart Failure (from ASCEND-HF). J Cardiovasc Transl Res. 2020 08; 13(4):540-548. PMID: 31933144.
      Citations: 2     Fields:    Translation:Humans
    62. Patel PA, Ambrosy AP, Phelan M, Alenezi F, Chiswell K, Van Dyke MK, Tomfohr J, Honarpour N, Velazquez EJ. Association between systolic ejection time and outcomes in heart failure by ejection fraction. Eur J Heart Fail. 2020 07; 22(7):1174-1182. PMID: 31863532; PMCID: PMC7493053.
      Citations: 12     Fields:    Translation:Humans
    63. Sidney S, Go AS, Jaffe MG, Solomon MD, Ambrosy AP, Rana JS. Association Between Aging of the US Population and Heart Disease Mortality From 2011 to 2017. JAMA Cardiol. 2019 12 01; 4(12):1280-1286. PMID: 31663094; PMCID: PMC6822092.
      Citations: 63     Fields:    Translation:Humans
    64. Go AS, Ambrosy AP, Kheder K, Fan D, Sung SH, Inveiss AI, Romo-LeTourneau V, Thomas SM, Koren A, Lo JC, Kaiser Permanente Cholesterol-Lowering Therapy in High-Risk Adults: Management and Patient Risks (KP. Statin Therapy and Risk of Incident Diabetes Mellitus in Adults With Cardiovascular Risk Factors. Am J Cardiol. 2020 02 15; 125(4):534-541. PMID: 31848029.
      Citations: 3     Fields:    Translation:Humans
    65. Chioncel O, Ambrosy AP. Hyperglycemia and outcomes in acute heart failure - A bittersweet relationship. Int J Cardiol. 2020 02 01; 300:196-197. PMID: 31776008.
      Citations: 1     Fields:    Translation:Humans
    66. Fudim M, Kelly JP, Jones AD, AbouEzzeddine OF, Ambrosy AP, Greene SJ, Reddy YNV, Anstrom KJ, Alhanti B, Lewis GD, Hernandez AF, Felker GM. Are existing and emerging biomarkers associated with cardiorespiratory fitness in patients with chronic heart failure? Am Heart J. 2020 02; 220:97-107. PMID: 31805424; PMCID: PMC7008085.
      Citations: 5     Fields:    Translation:Humans
    67. Blumer V, Greene SJ, Sun JL, Bart BA, Ambrosy AP, Butler J, DeVore AD, Fudim M, Hernandez AF, McNulty SE, Felker GM, Mentz RJ. Haemoconcentration during treatment of acute heart failure with cardiorenal syndrome: from the CARRESS-HF trial. Eur J Heart Fail. 2019 11; 21(11):1472-1476. PMID: 31452311.
      Citations: 2     Fields:    Translation:Humans
    68. Ambrosy AP, Fudim M, Chioncel O. Should providers prescribe sacubitril/valsartan based on trial eligibility, approval indication, or guideline recommendations? Eur J Heart Fail. 2019 11; 21(11):1398-1401. PMID: 31332924.
      Citations: 3     Fields:    Translation:Humans
    69. Fudim M, Ambrosy AP. A Balancing Act: Preserving Renal Function and the Need for Decongestion. J Card Fail. 2019 08; 25(8):643-644. PMID: 31254625.
      Citations: 1     Fields:    Translation:Humans
    70. Ambrosy AP, DeVore AD, Velazquez EJ. In-hospital initiation of sacubitril/valsartan in acute decompensated heart failure: being in the right place at the right time. Eur J Heart Fail. 2019 08; 21(8):1008-1011. PMID: 31218805.
      Citations: 1     Fields:    Translation:Humans
    71. Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD. Erratum to 'The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions' [Eur J Heart Fail 2018;20:963-972]. Eur J Heart Fail. 2019 Jun; 21(6):819. PMID: 31222927.
      Citations:    Fields:    
    72. Samsky MD, Ambrosy AP, Youngson E, Liang L, Kaul P, Hernandez AF, Peterson ED, McAlister FA. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United States. JAMA Cardiol. 2019 Apr 10. PMID: 30969316.
      Citations: 34     Fields:    Translation:Humans
    73. Morrow DA, Velazquez EJ, DeVore AD, Desai AS, Duffy CI, Ambrosy AP, Gurmu Y, McCague K, Rocha R, Braunwald E. Clinical Outcomes in Patients With Acute Decompensated Heart Failure Randomly Assigned to Sacubitril/Valsartan or Enalapril in the PIONEER-HF Trial. Circulation. 2019 Apr 08. PMID: 30955360.
      Citations: 60     Fields:    Translation:Humans
    74. Ambrosy AP, Lewis GD, Malhotra R, Jones AD, Greene SJ, Fudim M, Coles A, Butler J, Sharma A, Hernandez AF, Mentz RJ. Identifying responders to oral iron supplementation in heart failure with a reduced ejection fraction: a post-hoc analysis of the IRONOUT-HF trial. J Cardiovasc Med (Hagerstown). 2019 Apr; 20(4):223-225. PMID: 30540649.
      Citations: 6     Fields:    Translation:Humans
    75. Hardwick AB, Ambrosy AP. Natriuretic peptides as a surrogate endpoint in clinical trials?-?a riddle wrapped in an enigma. Eur J Heart Fail. 2019 Mar 27. PMID: 30919550.
      Citations: 2     Fields:    Translation:Humans
    76. Ambrosy AP, Gurwitz JH, Tabada GH, Artz A, Schrier S, Rao SV, Barnhart HX, Reynolds K, Smith DH, Peterson PN, Sung SH, Cohen HJ, Go AS. Incident Anemia in Older Adults with Heart Failure Rate, Etiology, and Association with Outcomes. Eur Heart J Qual Care Clin Outcomes. 2019 Mar 07. PMID: 30847487.
      Citations: 2     Fields:    Translation:Humans
    77. Antohi EL, Ambrosy AP, Collins SP, Ahmed A, Iliescu VA, Cotter G, Pang PS, Butler J, Chioncel O. Therapeutic Advances in the Management of Acute Decompensated Heart Failure. Am J Ther. 2019 Mar/Apr; 26(2):e222-e233. PMID: 30839371.
      Citations: 8     Fields:    Translation:Humans
    78. Chioncel O, Collins SP, Ambrosy AP, Pang PS, Radu RI, Antohi EL, Masip J, Butler J, Iliescu VA. Therapeutic Advances in the Management of Cardiogenic Shock. Am J Ther. 2019 Mar/Apr; 26(2):e234-e247. PMID: 30839372.
      Citations: 4     Fields:    Translation:Humans
    79. Ambrosy AP, Lee KK. Applying data science approaches to identify frequent flyers in heart failure: rise of the machines. Eur J Heart Fail. 2019 03; 21(3):319-321. PMID: 30730099.
      Citations:    Fields:    Translation:Humans
    80. Greene SJ, Felker GM, Giczewska A, Kalogeropoulos AP, Ambrosy AP, Chakraborty H, DeVore AD, Fudim M, McNulty SE, Mentz RJ, Vaduganathan M, Hernandez AF, Butler J. Spironolactone in Acute Heart Failure Patients With Renal Dysfunction and Risk Factors for Diuretic Resistance: From the ATHENA-HF Trial. Can J Cardiol. 2019 09; 35(9):1097-1105. PMID: 31230825; PMCID: PMC6685766.
      Citations: 10     Fields:    Translation:Humans
    81. Soloveva A, Kobalava Z, Fudim M, Ambrosy AP, Villevalde S, Bayarsaikhan M, Garmash I, Naumenko M. Relationship of Liver Stiffness With Congestion in Patients Presenting With Acute Decompensated Heart Failure. J Card Fail. 2019 Mar; 25(3):176-187. PMID: 30721735.
      Citations: 19     Fields:    Translation:Humans
    82. Ambrosy AP, Stevens SR, Al-Khalidi HR, Rouleau JL, Bouabdallaoui N, Carson PE, Adlbrecht C, Cleland JGF, Dabrowski R, Golba KS, Pina IL, Sueta CA, Roy A, Sopko G, Bonow RO, Velazquez EJ. Burden of medical co-morbidities and benefit from surgical revascularization in patients with ischaemic cardiomyopathy. Eur J Heart Fail. 2019 03; 21(3):373-381. PMID: 30698316.
      Citations: 5     Fields:    Translation:Humans
    83. Chioncel O, Ambrosy AP. Trimethylamine N-oxide and risk of heart failure progression: marker or mediator of disease. Eur J Heart Fail. 2019 Jan 09. PMID: 30623560.
      Citations: 5     Fields:    Translation:Humans
    84. Fudim M, Ambrosy AP, Sun JL, Anstrom KJ, Bart BA, Butler J, AbouEzzeddine O, Greene SJ, Mentz RJ, Redfield MM, Reddy YNV, Vaduganathan M, Braunwald E, Hernandez AF, Borlaug BA, Felker GM. High-Sensitivity Troponin I in Hospitalized and Ambulatory Patients With Heart Failure With Preserved Ejection Fraction: Insights From the Heart Failure Clinical Research Network. J Am Heart Assoc. 2018 Dec 18; 7(24):e010364. PMID: 30561266.
      Citations: 15     Fields:    Translation:HumansCells
    85. Ambrosy AP, Parzynski CS, Friedman DJ, Fudim M, Hernandez AF, Fonarow GC, Masoudi FA, Al-Khatib SM. Is Time From Last Hospitalization for Heart Failure to Placement of a Primary Prevention Implantable Cardioverter-Defibrillator Associated With Patient Outcomes? Circulation. 2018 Dec 11; 138(24):2787-2797. PMID: 30565983.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    86. Alenezi F, Ambrosy AP, Phelan M, Chiswell K, Abudaqa L, Alajmi H, Kisslo J, Velazquez EJ. Left Ventricular Global Longitudinal Strain Can Reliably Be Measured from a Single Apical Four-Chamber View in Patients with Heart Failure. J Am Soc Echocardiogr. 2019 Feb; 32(2):317-318. PMID: 30552031.
      Citations: 9     Fields:    Translation:Humans
    87. Greene SJ, Fonarow GC, Solomon SD, Subacius HP, Vaduganathan M, Ambrosy AP, Fudim M, Böhm M, Maggioni AP, Lewis EF, Zannad F, Butler J. Relationship between timing of trial randomization, protocol completion, and clinical outcomes among patients hospitalized for heart failure: from the ASTRONAUT trial. Eur J Heart Fail. 2018 12; 20(12):1760-1763. PMID: 30415473.
      Citations: 1     Fields:    Translation:Humans
    88. Velazquez EJ, Morrow DA, DeVore AD, Duffy CI, Ambrosy AP, McCague K, Rocha R, Braunwald E. Angiotensin-Neprilysin Inhibition in Acute Decompensated Heart Failure. N Engl J Med. 2019 02 07; 380(6):539-548. PMID: 30415601.
      Citations: 399     Fields:    Translation:Humans
    89. Bouabdallaoui N, Stevens SR, Doenst T, Petrie MC, Al-Attar N, Ali IS, Ambrosy AP, Barton AK, Cartier R, Cherniavsky A, Demondion P, Desvigne-Nickens P, Favaloro RR, Gradinac S, Heinisch P, Jain A, Jasinski M, Jouan J, Kalil RAK, Menicanti L, Michler RE, Rao V, Smith PK, Zembala M, Velazquez EJ, Al-Khalidi HR, Rouleau JL. Society of Thoracic Surgeons Risk Score and EuroSCORE-2 Appropriately Assess 30-Day Postoperative Mortality in the STICH Trial and a Contemporary Cohort of Patients With Left Ventricular Dysfunction Undergoing Surgical Revascularization. Circ Heart Fail. 2018 Nov; 11(11):e005531. PMID: 30571194.
      Citations: 13     Fields:    Translation:Humans
    90. Chioncel O, Ambrosy AP. Undiagnosed dysglycemia in patients hospitalized for worsening heart failure: not so sweet after all. Eur J Prev Cardiol. 2019 Jan; 26(1):68-71. PMID: 30370791.
      Citations:    Fields:    Translation:Humans
    91. Campbell CI, Parthasarathy S, Altschuler A, Young-Wolff KC, Satre DD. Characteristics of patients with substance use disorder before and after the Affordable Care Act. Drug Alcohol Depend. 2018 12 01; 193:124-130. PMID: 30366189.
      Citations: 3     Fields:    Translation:Humans
    92. Greene SJ, Mentz RJ, Fiuzat M, Butler J, Solomon SD, Ambrosy AP, Mehta C, Teerlink JR, Zannad F, O'Connor CM. Reassessing the Role of Surrogate End Points in Drug Development for Heart Failure. Circulation. 2018 Sep 04; 138(10):1039-1053. PMID: 30354535.
      Citations: 12     Fields:    Translation:Humans
    93. Sharma A, Ambrosy AP, DeVore AD, Margulies KB, McNulty SE, Mentz RJ, Hernandez AF, Michael Felker G, Cooper LB, Lala A, Vader J, Groake JD, Borlaug BA, Velazquez EJ. Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: insights from the FIGHT trial. ESC Heart Fail. 2018 12; 5(6):1035-1043. PMID: 30120812.
      Citations: 14     Fields:    Translation:Humans
    94. Ambrosy AP, Cerbin LP, Fudim M, Clare RM, Lokhnygina Y, Braunwald E, Califf RM, Cannon CP, Tershakovec AM, Roe MT, Blazing MA. Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status. Am J Cardiol. 2018 Nov 01; 122(9):1451-1458. PMID: 30180960.
      Citations:    Fields:    Translation:Humans
    95. Fudim M, O'Connor CM, Mulder H, Coles A, Bhatt AS, Ambrosy AP, Kraus WE, Piña IL, Whellan DJ, Mentz RJ. Loop diuretic adjustments in patients with chronic heart failure: Insights from HF-ACTION. Am Heart J. 2018 Nov; 205:133-141. PMID: 30158057.
      Citations: 5     Fields:    Translation:Humans
    96. Chioncel O, Collins SP, Ambrosy AP, Pang PS, Antohi EL, Iliescu VA, Maggioni AP, Butler J, Mebazaa A. Improving Postdischarge Outcomes in Acute Heart Failure. Am J Ther. 2018 Jul/Aug; 25(4):e475-e486. PMID: 29985826.
      Citations: 8     Fields:    Translation:Humans
    97. Njoroge JN, Cheema B, Ambrosy AP, Greene SJ, Collins SP, Vaduganathan M, Mebazaa A, Chioncel O, Butler J, Gheorghiade M. Expanded algorithm for managing patients with acute decompensated heart failure. Heart Fail Rev. 2018 07; 23(4):597-607. PMID: 29611010.
      Citations: 5     Fields:    Translation:Humans
    98. Ambrosy AP, Mulder H, Coles A, Krauss WE, Lam CSP, McCullough PA, Pina I, Tromp J, Whellan DJ, O'Connor CM, Mentz RJ. Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction. Am J Cardiol. 2018 Sep 15; 122(6):999-1007. PMID: 30269900.
      Citations: 4     Fields:    Translation:Humans
    99. Ambrosy AP, Chioncel O. Combination drug therapy in heart failure: greater than the sum of its parts. Eur J Heart Fail. 2018 09; 20(9):1323-1325. PMID: 29932484.
      Citations:    Fields:    Translation:Humans
    100. Vaduganathan M, Patel RB, Mentz RJ, Subacius H, Chatterjee NA, Greene SJ, Ambrosy AP, Maggioni AP, Udelson JE, Swedberg K, Konstam MA, O'Connor CM, Butler J, Gheorghiade M, Zannad F. Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). Am J Cardiol. 2018 Jul 15; 122(2):255-260. PMID: 29731121.
      Citations: 2     Fields:    Translation:Humans
    101. Cerbin LP, Ambrosy AP, Greene SJ, Armstrong PW, Butler J, Coles A, DeVore AD, Ezekowitz JA, Hernandez AF, Metra M, Starling RC, Tang W, Teerlink JR, Voors AA, Wu A, O'Connor CM, Mentz RJ. Is Time of the Essence? The Impact of Time of Hospital Presentation in Acute Heart Failure: Insights From ASCEND-HF Trial. JACC Heart Fail. 2018 Apr; 6(4):298-307. PMID: 29525328.
      Citations: 4     Fields:    Translation:Humans
    102. Ambrosy AP, Mentz RJ, Fiuzat M, Cleland JGF, Greene SJ, O'Connor CM, Teerlink JR, Zannad F, Solomon SD. The role of angiotensin receptor-neprilysin inhibitors in cardiovascular disease-existing evidence, knowledge gaps, and future directions. Eur J Heart Fail. 2018 06; 20(6):963-972. PMID: 29464817.
      Citations: 10     Fields:    Translation:Humans
    103. Ambrosy AP, Velazquez EJ. Angiotensin receptor-neprilysin inhibitor therapy in heart failure: An end that justifies the means. Am Heart J. 2018 05; 199:176-177. PMID: 29754658.
      Citations:    Fields:    Translation:Humans
    104. Ambrosy AP, Bhatt AS, Stebbins AL, Wruck LM, Fudim M, Greene SJ, Kraus WE, O'Connor CM, Piña IL, Whellan DJ, Mentz RJ. Prevalent digoxin use and subsequent risk of death or hospitalization in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) randomized controlled trial. Am Heart J. 2018 05; 199:97-104. PMID: 29754673.
      Citations: 3     Fields:    Translation:Humans
    105. Bhatt AS, Cooper LB, Ambrosy AP, Clare RM, Coles A, Joyce E, Krishnamoorthy A, Butler J, Felker GM, Ezekowitz JA, Armstrong PW, Hernandez AF, O'Connor CM, Mentz RJ. Interaction of Body Mass Index on the Association Between N-Terminal-Pro-b-Type Natriuretic Peptide and Morbidity and Mortality in Patients With Acute Heart Failure: Findings From ASCEND-HF (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). J Am Heart Assoc. 2018 Feb 03; 7(3). PMID: 29431103.
      Citations: 9     Fields:    Translation:Humans
    106. Campbell CI, Bahorik AL, VanVeldhuisen P, Weisner C, Rubinstein AL, Ray GT. Use of a prescription opioid registry to examine opioid misuse and overdose in an integrated health system. Prev Med. 2018 05; 110:31-37. PMID: 29410132.
      Citations: 30     Fields:    Translation:Humans
    107. Velazquez EJ, Morrow DA, DeVore AD, Ambrosy AP, Duffy CI, McCague K, Hernandez AF, Rocha RA, Braunwald E. Rationale and design of the comParIson Of sacubitril/valsartaN versus Enalapril on Effect on nt-pRo-bnp in patients stabilized from an acute Heart Failure episode (PIONEER-HF) trial. Am Heart J. 2018 04; 198:145-151. PMID: 29653636.
      Citations: 27     Fields:    Translation:Humans
    108. Ambrosy AP, Fudim M, Chioncel O. Sudden cardiac death following admission for acute heart failure: adding insult to injury. Eur J Heart Fail. 2018 03; 20(3):533-535. PMID: 29314460.
      Citations: 3     Fields:    Translation:Humans
    109. Chioncel O, Collins SP, Greene SJ, Pang PS, Ambrosy AP, Antohi EL, Vaduganathan M, Butler J, Gheorghiade M. Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure. Card Fail Rev. 2017 Nov; 3(2):122-129. PMID: 29387465.
      Citations: 15     
    110. Fudim M, O'Connor CM, Dunning A, Ambrosy AP, Armstrong PW, Coles A, Ezekowitz JA, Greene SJ, Metra M, Starling RC, Voors AA, Hernandez AF, Michael Felker G, Mentz RJ. Aetiology, timing and clinical predictors of early vs. late readmission following index hospitalization for acute heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2018 02; 20(2):304-314. PMID: 29082629.
      Citations: 23     Fields:    Translation:Humans
    111. Cheema B, Ambrosy AP, Kaplan RM, Senni M, Fonarow GC, Chioncel O, Butler J, Gheorghiade M. Lessons learned in acute heart failure. Eur J Heart Fail. 2018 04; 20(4):630-641. PMID: 29082676.
      Citations: 14     Fields:    Translation:Humans
    112. Greene SJ, Butler J, Fonarow GC, Subacius HP, Ambrosy AP, Vaduganathan M, Triggiani M, Solomon SD, Lewis EF, Maggioni AP, Böhm M, Chioncel O, Nodari S, Senni M, Zannad F, Gheorghiade M. Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. Eur J Heart Fail. 2018 02; 20(2):281-291. PMID: 29044915.
      Citations: 19     Fields:    Translation:Humans
    113. Ambrosy AP, Gheorghiade M. Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement. Eur J Heart Fail. 2017 11; 19(11):1424-1426. PMID: 28786154.
      Citations: 7     Fields:    Translation:Humans
    114. Ambrosy AP, Gheorghiade M. Clinical profiles in acute heart failure: one size fits all or not at all? Eur J Heart Fail. 2017 10; 19(10):1255-1257. PMID: 28786165.
      Citations: 1     Fields:    Translation:Humans
    115. Bhatt AS, Ambrosy AP, Velazquez EJ. Adverse Remodeling and Reverse Remodeling After Myocardial Infarction. Curr Cardiol Rep. 2017 08; 19(8):71. PMID: 28660552.
      Citations: 104     Fields:    Translation:Humans
    116. Cerbin LP, Ambrosy AP, Mentz RJ. Building the case for aerobic exercise in ambulatory patients with heart failure and a reduced ejection fraction. Am Heart J. 2017 Oct; 192:e3. PMID: 28938970.
      Citations:    Fields:    Translation:Humans
    117. Ambrosy AP, Butler J, Gheorghiade M. Clinical trials in acute heart failure: beginning of the end or end of the beginning? Eur J Heart Fail. 2017 11; 19(11):1358-1360. PMID: 28656635.
      Citations: 5     Fields:    Translation:Humans
    118. Greene SJ, Hernandez AF, Dunning A, Ambrosy AP, Armstrong PW, Butler J, Cerbin LP, Coles A, Ezekowitz JA, Metra M, Starling RC, Teerlink JR, Voors AA, O'Connor CM, Mentz RJ. Hospitalization for Recently Diagnosed Versus Worsening Chronic Heart Failure: From the ASCEND-HF Trial. J Am Coll Cardiol. 2017 Jun 27; 69(25):3029-3039. PMID: 28641792.
      Citations: 30     Fields:    Translation:Humans
    119. Campbell CI, Bahorik AL, Kline-Simon AH, Satre DD. The role of marijuana use disorder in predicting emergency department and inpatient encounters: A retrospective cohort study. Drug Alcohol Depend. 2017 09 01; 178:170-175. PMID: 28651153.
      Citations: 14     Fields:    Translation:Humans
    120. Ambrosy AP, Bhatt AS, Gallup D, Anstrom KJ, Butler J, DeVore AD, Felker GM, Fudim M, Greene SJ, Hernandez AF, Kelly JP, Samsky MD, Mentz RJ. Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network). Am J Cardiol. 2017 07 01; 120(1):98-105. PMID: 28479167.
      Citations: 7     Fields:    Translation:Humans
    121. Cerbin LP, Ambrosy AP, Mentz RJ. Reply: Factors That May Affect Body Change During and After Hospitalization for Acute Heart Failure. JACC Heart Fail. 2017 04; 5(4):311-312. PMID: 28359420.
      Citations:    Fields:    Translation:Humans
    122. Egwim C, Dixon B, Ambrosy AP, Mentz RJ. Global Variations in Patient Populations and Outcomes in Heart Failure Clinical Trials. Curr Heart Fail Rep. 2017 02; 14(1):30-39. PMID: 28185163.
      Citations: 4     Fields:    Translation:Humans
    123. Ambrosy AP, Cerbin LP, DeVore AD, Greene SJ, Kraus WE, O'Connor CM, Piña IL, Whellan DJ, Wojdyla D, Wu A, Mentz RJ. Aerobic exercise training and general health status in ambulatory heart failure patients with a reduced ejection fraction-Findings from the Heart Failure and A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)trial. Am Heart J. 2017 Apr; 186:130-138. PMID: 28454828.
      Citations: 11     Fields:    Translation:Humans
    124. Ambrosy AP, Cerbin LP, Armstrong PW, Butler J, Coles A, DeVore AD, Dunlap ME, Ezekowitz JA, Felker GM, Fudim M, Greene SJ, Hernandez AF, O'Connor CM, Schulte P, Starling RC, Teerlink JR, Voors AA, Mentz RJ. Body Weight Change During and After Hospitalization for Acute Heart Failure: Patient Characteristics, Markers of Congestion, and Outcomes: Findings From the ASCEND-HF Trial. JACC Heart Fail. 2017 01; 5(1):1-13. PMID: 28034373.
      Citations: 49     Fields:    Translation:Humans
    125. Greene SJ, Fonarow GC, Solomon SD, Subacius HP, Ambrosy AP, Vaduganathan M, Maggioni AP, Böhm M, Lewis EF, Zannad F, Butler J, Gheorghiade M. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. Eur J Heart Fail. 2017 04; 19(4):552-562. PMID: 27748006.
      Citations: 13     Fields:    Translation:Humans
    126. Greene SJ, Hernandez AF, Sun JL, Metra M, Butler J, Ambrosy AP, Ezekowitz JA, Starling RC, Teerlink JR, Schulte PJ, Voors AA, Armstrong PW, O'Connor CM, Mentz RJ. Influence of Clinical Trial Site Enrollment on Patient Characteristics, Protocol Completion, and End Points: Insights From the ASCEND-HF Trial (Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure). Circ Heart Fail. 2016 09; 9(9). PMID: 27623769.
      Citations: 9     Fields:    Translation:Humans
    127. Campbell CI, Sterling S, Chi FW, Kline-Simon AH. Marijuana use and service utilization among adolescents 7 years post substance use treatment. Drug Alcohol Depend. 2016 Nov 01; 168:1-7. PMID: 27606492.
      Citations: 2     Fields:    Translation:Humans
    128. Ambrosy AP, Gheorghiade M. Targeting digoxin dosing to serum concentration: is the bullseye too small? Eur J Heart Fail. 2016 08; 18(8):1082-4. PMID: 27492642.
      Citations: 2     Fields:    Translation:Humans
    129. Chioncel O, Collins SP, Greene SJ, Ambrosy AP, Vaduganathan M, Macarie C, Butler J, Gheorghiade M. Natriuretic peptide-guided management in heart failure. J Cardiovasc Med (Hagerstown). 2016 Aug; 17(8):556-68. PMID: 27110656.
      Citations: 10     Fields:    Translation:Humans
    130. Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, Kwok BW, Reyes EB, Krum H, Pieske B, Greene SJ, Ambrosy AP, Kelly JP, Zannad F, Pitt B, Lam CS. Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps. JACC Heart Fail. 2016 06; 4(6):419-27. PMID: 27256745.
      Citations: 26     Fields:    Translation:Humans
    131. Ambrosy AP, Pang PS, Gheorghiade M. Digoxin for Worsening Chronic Heart Failure: Underutilized and Underrated. JACC Heart Fail. 2016 05; 4(5):365-7. PMID: 27126283.
      Citations: 2     Fields:    Translation:Humans
    132. Ambrosy AP, Khan H, Udelson JE, Mentz RJ, Chioncel O, Greene SJ, Vaduganathan M, Subacuis HP, Konstam MA, Swedberg K, Zannad F, Maggioni AP, Gheorghiade M, Butler J. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Circ Heart Fail. 2016 05; 9(5). PMID: 27140204.
      Citations: 10     Fields:    Translation:Humans
    133. Mecklai A, Subacius H, Konstam MA, Gheorghiade M, Butler J, Ambrosy AP, Katz SD. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial. JACC Heart Fail. 2016 07; 4(7):580-588. PMID: 27039131.
      Citations: 5     Fields:    Translation:Humans
    134. Chioncel O, Ambrosy AP, Bubenek S, Filipescu D, Vinereanu D, Petris A, Christodorescu R, Macarie C, Gheorghiade M, Collins SP. Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. J Cardiovasc Med (Hagerstown). 2016 Feb; 17(2):92-104. PMID: 25252041.
      Citations: 9     Fields:    Translation:Humans
    135. Vaduganathan M, Marti CN, Mentz RJ, Greene SJ, Ambrosy AP, Subacius HP, Fonarow GC, Chioncel O, Bazari H, Maggioni AP, Zannad F, Konstam MA, Sato N, Gheorghiade M, Butler J. Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure. Am J Cardiol. 2016 Apr 01; 117(7):1144-50. PMID: 26851146.
      Citations: 16     Fields:    Translation:Humans
    136. Ambrosy AP, Hernandez AF, Armstrong PW, Butler J, Dunning A, Ezekowitz JA, Felker GM, Greene SJ, Kaul P, McMurray JJ, Metra M, O'Connor CM, Reed SD, Schulte PJ, Starling RC, Tang WH, Voors AA, Mentz RJ. The clinical course of health status and association with outcomes in patients hospitalized for heart failure: insights from ASCEND-HF. Eur J Heart Fail. 2016 Mar; 18(3):306-13. PMID: 26467269.
      Citations: 17     Fields:    Translation:Humans
    137. Ambrosy AP, Mentz RJ, Krishnamoorthy A, Greene SJ, Severance HW. Identifying Barriers and Practical Solutions to Conducting Site-Based Research in North America: Exploring Acute Heart Failure Trials As a Case Study. Heart Fail Clin. 2015 Oct; 11(4):581-9. PMID: 26462098.
      Citations: 5     Fields:    Translation:Humans
    138. Greene SJ, AlKhawam L, Ambrosy AP, Vaduganathan M, Mentz RJ. Hospitalized Heart Failure in the United States: Lessons Learned from Clinical Trial Populations. Heart Fail Clin. 2015 Oct; 11(4):591-601. PMID: 26462099.
      Citations: 1     Fields:    Translation:Humans
    139. Khan H, Greene SJ, Fonarow GC, Kalogeropoulos AP, Ambrosy AP, Maggioni AP, Zannad F, Konstam MA, Swedberg K, Yancy CW, Gheorghiade M, Butler J. Length of hospital stay and 30-day readmission following heart failure hospitalization: insights from the EVEREST trial. Eur J Heart Fail. 2015 Oct; 17(10):1022-31. PMID: 25960401.
      Citations: 22     Fields:    Translation:Humans
    140. Chioncel O, Ambrosy AP, Filipescu D, Bubenek S, Vinereanu D, Petris A, Collins SP, Macarie C, Gheorghiade M. Patterns of intensive care unit admissions in patients hospitalized for heart failure: insights from the RO-AHFS registry. J Cardiovasc Med (Hagerstown). 2015 May; 16(5):331-40. PMID: 24710424.
      Citations: 16     Fields:    Translation:Humans
    141. Chioncel O, Collins SP, Ambrosy AP, Gheorghiade M, Filippatos G. Pulmonary Oedema-Therapeutic Targets. Card Fail Rev. 2015 Apr; 1(1):38-45. PMID: 28785430.
      Citations: 5     
    142. Filippatos G, Khan SS, Ambrosy AP, Cleland JG, Collins SP, Lam CS, Angermann CE, Ertl G, Dahlström U, Hu D, Dickstein K, Perrone SV, Ghadanfar M, Bermann G, Noe A, Schweizer A, Maier T, Gheorghiade M. International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registry. Eur J Heart Fail. 2015 May; 17(5):527-33. PMID: 25754836.
      Citations: 10     Fields:    Translation:Humans
    143. Ambrosy AP, Dunn TP, Heidenreich PA. Effect of minor liver function test abnormalities and values within the normal range on survival in heart failure. Am J Cardiol. 2015 Apr 01; 115(7):938-41. PMID: 25708860.
      Citations: 8     Fields:    Translation:Humans
    144. Ambrosy AP, Gheorghiade M, Chioncel O, Mentz RJ, Butler J. Global perspectives in hospitalized heart failure: regional and ethnic variation in patient characteristics, management, and outcomes. Curr Heart Fail Rep. 2014 Dec; 11(4):416-27. PMID: 25252827.
      Citations: 22     Fields:    Translation:Humans
    145. Vaduganathan M, Greene SJ, Ambrosy AP, Gheorghiade M. Lipids, statins, and clinical outcomes in heart failure: rethinking the data. Heart Fail Rev. 2014 Nov; 19(6):695-8. PMID: 24509934.
      Citations: 3     Fields:    Translation:Humans
    146. Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Subacius HP, Chioncel O, Maggioni AP, Swedberg K, Zannad F, Konstam MA, Senni M, Givertz MM, Butler J, Gheorghiade M. Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial). Am J Cardiol. 2014 Dec 01; 114(11):1713-21. PMID: 25312638.
      Citations: 27     Fields:    Translation:Humans
    147. Greene SJ, Shah AN, Butler J, Ambrosy AP, Anker SD, Chioncel O, Collins SP, Dinh W, Dunnmon PM, Fonarow GC, Lam CS, Mentz RJ, Pieske B, Roessig L, Rosano GM, Sato N, Vaduganathan M, Gheorghiade M. Designing effective drug and device development programs for hospitalized heart failure: a proposal for pretrial registries. Am Heart J. 2014 Aug; 168(2):142-9. PMID: 25066552.
      Citations: 10     Fields:    Translation:Humans
    148. Mentz RJ, Greene SJ, Ambrosy AP, Vaduganathan M, Subacius HP, Swedberg K, Maggioni AP, Nodari S, Ponikowski P, Anker SD, Butler J, Gheorghiade M. Clinical profile and prognostic value of anemia at the time of admission and discharge among patients hospitalized for heart failure with reduced ejection fraction: findings from the EVEREST trial. Circ Heart Fail. 2014 May; 7(3):401-8. PMID: 24737459.
      Citations: 13     Fields:    Translation:Humans
    149. Ambrosy AP, Butler J, Ahmed A, Vaduganathan M, van Veldhuisen DJ, Colucci WS, Gheorghiade M. The use of digoxin in patients with worsening chronic heart failure: reconsidering an old drug to reduce hospital admissions. J Am Coll Cardiol. 2014 May 13; 63(18):1823-32. PMID: 24613328.
      Citations: 30     Fields:    Translation:HumansAnimals
    150. Ambrosy AP, Fonarow GC, Butler J, Chioncel O, Greene SJ, Vaduganathan M, Nodari S, Lam CSP, Sato N, Shah AN, Gheorghiade M. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014 Apr 01; 63(12):1123-1133. PMID: 24491689.
      Citations: 777     Fields:    Translation:Humans
    151. Vaduganathan M, Greene SJ, Ambrosy AP, Mentz RJ, Fonarow GC, Zannad F, Maggioni AP, Konstam MA, Subacius HP, Nodari S, Butler J, Gheorghiade M. Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial). Am J Cardiol. 2013 Dec 01; 112(11):1763-9. PMID: 24095030.
      Citations: 3     Fields:    Translation:Humans
    152. Greene SJ, Gheorghiade M, Vaduganathan M, Ambrosy AP, Mentz RJ, Subacius H, Maggioni AP, Nodari S, Konstam MA, Butler J, Filippatos G. Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Eur J Heart Fail. 2013 Dec; 15(12):1401-11. PMID: 23845795.
      Citations: 62     Fields:    Translation:Humans
    153. Ambrosy AP, Gheorghiade M, Bubenek S, Vinereanu D, Vaduganathan M, Macarie C, Chioncel O. The predictive value of transaminases at admission in patients hospitalized for heart failure: findings from the RO-AHFS registry. Eur Heart J Acute Cardiovasc Care. 2013 Jun; 2(2):99-108. PMID: 24222818.
      Citations: 9     Fields:    Translation:Humans
    154. Ambrosy AP, Witteles RM. Not time to RELAX in acute heart failure. Lancet. 2013 May 25; 381(9880):1813. PMID: 23706797.
      Citations: 1     Fields:    Translation:Humans
    155. Gheorghiade M, Vaduganathan M, Ambrosy A, Böhm M, Campia U, Cleland JG, Fedele F, Fonarow GC, Maggioni AP, Mebazaa A, Mehra M, Metra M, Nodari S, Pang PS, Ponikowski P, Sabbah HN, Komajda M, Butler J. Current management and future directions for the treatment of patients hospitalized for heart failure with low blood pressure. Heart Fail Rev. 2013 Mar; 18(2):107-22. PMID: 22581217.
      Citations: 21     Fields:    Translation:Humans
    156. Huang RJ, Ambrosy AP, Triadafilopoulos G. Hepatic abscess with biliary communication following transarterial chemoembolization of hepatocellular carcinoma. Dig Dis Sci. 2013 Sep; 58(9):2463-5. PMID: 23423503.
      Citations: 3     Fields:    Translation:Humans
    157. Vaduganathan M, Greene SJ, Ambrosy AP, Gheorghiade M, Butler J. The disconnect between phase II and phase III trials of drugs for heart failure. Nat Rev Cardiol. 2013 Feb; 10(2):85-97. PMID: 23296069.
      Citations: 27     Fields:    Translation:HumansAnimals
    158. Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, Maggioni AP, Cook T, Swedberg K, Burnett JC, Grinfeld L, Udelson JE, Zannad F, Gheorghiade M. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013 Mar; 34(11):835-43. PMID: 23293303.
      Citations: 202     Fields:    Translation:Humans
    159. Ambrosy AP, Vaduganathan M, Mentz RJ, Greene SJ, Subacius H, Konstam MA, Maggioni AP, Swedberg K, Gheorghiade M. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Am Heart J. 2013 Feb; 165(2):216-25. PMID: 23351825.
      Citations: 43     Fields:    Translation:Humans
    160. Lanfear DE, Sabbah HN, Goldsmith SR, Greene SJ, Ambrosy AP, Fought AJ, Kwasny MJ, Swedberg K, Yancy CW, Konstam MA, Maggioni AP, Zannad F, Gheorghiade M. Association of arginine vasopressin levels with outcomes and the effect of V2 blockade in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2013 Jan; 6(1):47-52. PMID: 23239836.
      Citations: 23     Fields:    Translation:Humans
    161. Butler J, Subacius H, Vaduganathan M, Fonarow GC, Ambrosy AP, Konstam MA, Maggioni A, Mentz RJ, Swedberg K, Zannad F, Gheorghiade M. Relationship between clinical trial site enrollment with participant characteristics, protocol completion, and outcomes: insights from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) trial. J Am Coll Cardiol. 2013 Feb 05; 61(5):571-9. PMID: 23246389.
      Citations: 21     Fields:    Translation:Humans
    162. Greene SJ, Vaduganathan M, Lupi L, Ambrosy AP, Mentz RJ, Konstam MA, Nodari S, Subacius HP, Fonarow GC, Bonow RO, Gheorghiade M. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Am J Cardiol. 2013 Feb 15; 111(4):574-81. PMID: 23206923.
      Citations: 23     Fields:    Translation:Humans
    163. Mentz RJ, Chung MJ, Gheorghiade M, Pang PS, Kwasny MJ, Ambrosy AP, Vaduganathan M, O'Connor CM, Swedberg K, Zannad F, Konstam MA, Maggioni AP. Atrial fibrillation or flutter on initial electrocardiogram is associated with worse outcomes in patients admitted for worsening heart failure with reduced ejection fraction: findings from the EVEREST Trial. Am Heart J. 2012 Dec; 164(6):884-92.e2. PMID: 23194489.
      Citations: 10     Fields:    Translation:Humans
    164. Vaduganathan M, Ambrosy AP, Greene SJ, Mentz RJ, Subacius HP, Maggioni AP, Swedberg K, Nodari S, Zannad F, Konstam MA, Butler J, Gheorghiade M. Predictive value of low relative lymphocyte count in patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial. Circ Heart Fail. 2012 Nov; 5(6):750-8. PMID: 23051949.
      Citations: 53     Fields:    Translation:Humans
    165. Mentz RJ, Allen BD, Kwasny MJ, Konstam MA, Udelson JE, Ambrosy AP, Fought AJ, Vaduganathan M, O'Connor CM, Zannad F, Maggioni AP, Swedberg K, Bonow RO, Gheorghiade M. Influence of documented history of coronary artery disease on outcomes in patients admitted for worsening heart failure with reduced ejection fraction in the EVEREST trial. Eur J Heart Fail. 2013 Jan; 15(1):61-8. PMID: 22968743.
      Citations: 11     Fields:    Translation:Humans
    166. Ambrosy AP, Kunz PL, Fisher GA, Witteles RM. Capecitabine-induced chest pain relieved by diltiazem. Am J Cardiol. 2012 Dec 01; 110(11):1623-6. PMID: 22939579.
      Citations: 13     Fields:    Translation:HumansPHPublic Health
    167. Mentz RJ, Schmidt PH, Kwasny MJ, Ambrosy AP, O'Connor CM, Konstam MA, Zannad F, Maggioni AP, Swedberg K, Gheorghiade M. The impact of chronic obstructive pulmonary disease in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST Trial. J Card Fail. 2012 Jul; 18(7):515-23. PMID: 22748484.
      Citations: 22     Fields:    Translation:Humans
    168. Ambrosy AP, Fonarow GC, Albert NM, Curtis AB, Heywood JT, Mehra MR, O'Connor CM, Reynolds D, Walsh MN, Yancy CW, Gheorghiade M. B-type natriuretic peptide assessment in ambulatory heart failure patients: insights from IMPROVE HF. J Cardiovasc Med (Hagerstown). 2012 Jun; 13(6):360-7. PMID: 22472850.
      Citations:    Fields:    Translation:Humans
    169. Gheorghiade M, Pang PS, Ambrosy AP, Lan G, Schmidt P, Filippatos G, Konstam M, Swedberg K, Cook T, Traver B, Maggioni A, Burnett J, Grinfeld L, Udelson J, Zannad F. A comprehensive, longitudinal description of the in-hospital and post-discharge clinical, laboratory, and neurohormonal course of patients with heart failure who die or are re-hospitalized within 90 days: analysis from the EVEREST trial. Heart Fail Rev. 2012 May; 17(3):485-509. PMID: 21932146.
      Citations: 39     Fields:    Translation:Humans
    170. Ambrosy AP, Vaduganathan M, Huffman MD, Khan S, Kwasny MJ, Fought AJ, Maggioni AP, Swedberg K, Konstam MA, Zannad F, Gheorghiade M. Clinical course and predictive value of liver function tests in patients hospitalized for worsening heart failure with reduced ejection fraction: an analysis of the EVEREST trial. Eur J Heart Fail. 2012 Mar; 14(3):302-11. PMID: 22357577.
      Citations: 70     Fields:    Translation:Humans
    171. Gheorghiade M, Ambrosy AP, Ferrandi M, Ferrari P. Combining SERCA2a activation and Na-K ATPase inhibition: a promising new approach to managing acute heart failure syndromes with low cardiac output. Discov Med. 2011 Aug; 12(63):141-51. PMID: 21878191.
      Citations: 12     Fields:    Translation:HumansAnimals
    172. Blair JE, Pang PS, Schrier RW, Metra M, Traver B, Cook T, Campia U, Ambrosy A, Burnett JC, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Konstam MA, Gheorghiade M. Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial. Eur Heart J. 2011 Oct; 32(20):2563-72. PMID: 21785107.
      Citations: 42     Fields:    Translation:Humans
    173. Keeling AN, Flaherty JD, Davarpanah AH, Ambrosy A, Farrelly CT, Harinstein ME, Flamm SL, Abecassis MI, Skaro AI, Carr JC, Gheorghiade M. Coronary multidetector computed tomographic angiography to evaluate coronary artery disease in liver transplant candidates: methods, feasibility and initial experience. J Cardiovasc Med (Hagerstown). 2011 Jul; 12(7):460-8. PMID: 21610507.
      Citations: 14     Fields:    Translation:Humans
    174. Chioncel O, Vinereanu D, Datcu M, Ionescu DD, Capalneanu R, Brukner I, Dorobantu M, Ambrosy A, Macarie C, Gheorghiade M. The Romanian Acute Heart Failure Syndromes (RO-AHFS) registry. Am Heart J. 2011 Jul; 162(1):142-53.e1. PMID: 21742101.
      Citations: 23     Fields:    Translation:Humans
    175. Ambrosy A, Gheorghiade M. Eplerenone reduces risk of cardiovascular death or hospitalisation in heart failure patients with reduced ejection fraction. Evid Based Med. 2011 Aug; 16(4):121-2. PMID: 21558564.
      Citations:    Fields:    
    176. Ambrosy A, Wilcox J, Nodari S, Gheorghiade M. Acute heart failure syndromes: assessment and reconstructing the heart. J Cardiovasc Med (Hagerstown). 2011 Apr; 12(4):258-63. PMID: 21386686.
      Citations:    Fields:    Translation:Humans
    177. Ambrosy A, Goldsmith SR, Gheorghiade M. Tolvaptan for the treatment of heart failure: a review of the literature. Expert Opin Pharmacother. 2011 Apr; 12(6):961-76. PMID: 21401442.
      Citations: 11     Fields:    Translation:HumansAnimals
    178. Gheorghiade M, Ambrosy A. Heart failure in 2010: one step forward, two steps back. Nat Rev Cardiol. 2011 Feb; 8(2):72-3. PMID: 21270845.
      Citations: 4     Fields:    Translation:Humans
    179. Campbell CI, Weisner C, Leresche L, Ray GT, Saunders K, Sullivan MD, Banta-Green CJ, Merrill JO, Silverberg MJ, Boudreau D, Satre DD, Von Korff M. Age and gender trends in long-term opioid analgesic use for noncancer pain. Am J Public Health. 2010 Dec; 100(12):2541-7. PMID: 20724688.
      Citations: 160     Fields:    Translation:Humans
    180. Nyame YA, Ambrosy AP, Saps M, Adams PN, Dhroove GN, Suresh S. Recurrent headaches in children: an epidemiological survey of two middle schools in inner city Chicago. Pain Pract. 2010 May-Jun; 10(3):214-21. PMID: 20070550.
      Citations: 2     Fields:    Translation:Humans
    181. Birmingham PK, Suresh S, Ambrosy A, Porfyris S. Parent-assisted or nurse-assisted epidural analgesia: is this feasible in pediatric patients? Paediatr Anaesth. 2009 Nov; 19(11):1084-9. PMID: 19807886.
      Citations: 1     Fields:    Translation:Humans
    182. Jagannathan N, Sohn L, Sawardekar A, Ambrosy A, Hagerty J, Chin A, Barsness K, Suresh S. Unilateral groin surgery in children: will the addition of an ultrasound-guided ilioinguinal nerve block enhance the duration of analgesia of a single-shot caudal block? Paediatr Anaesth. 2009 Sep; 19(9):892-8. PMID: 19627532.
      Citations: 8     Fields:    Translation:Humans
    183. Campbell CI, Alexander JA, Lemak CH. Organizational determinants of outpatient substance abuse treatment duration in women. J Subst Abuse Treat. 2009 Jul; 37(1):64-72. PMID: 19038526.
      Citations: 12     Fields:    Translation:Humans
    184. Campbell CI, Chi F, Sterling S, Kohn C, Weisner C. Self-initiated tobacco cessation and substance use outcomes among adolescents entering substance use treatment in a managed care organization. Addict Behav. 2009 Feb; 34(2):171-9. PMID: 19010600.
      Citations: 4     Fields:    Translation:Humans
    185. Campbell CI, Weisner C, Sterling S. Adolescents entering chemical dependency treatment in private managed care: ethnic differences in treatment initiation and retention. J Adolesc Health. 2006 Apr; 38(4):343-50. PMID: 16549294.
      Citations: 32     Fields:    Translation:Humans
    Concepts (430)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (59)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    -->

    © 2024 Kaiser Permanente